coronary vasodilatation
Recently Published Documents


TOTAL DOCUMENTS

96
(FIVE YEARS 1)

H-INDEX

25
(FIVE YEARS 0)

Author(s):  
Mridula Pachen ◽  
Yonis Abukar ◽  
Julia Shanks ◽  
Nigel Lever ◽  
Rohit Ramchandra

Activation of the carotid body (CB) using intracarotid potassium cyanide (KCN) injection increases coronary blood flow (CoBF). This increase in CoBF is considered to be mediated by co-activation of both the sympathetic and parasympathetic nerves to the heart. However, whether cardiac sympathetic nerve activity (cardiac SNA) actually increases during CB activation has not been determined previously. We hypothesized that activation of the CB would increase directly recorded cardiac SNA, which would cause coronary vasodilatation. Experiments were conducted in conscious sheep implanted with electrodes to record cardiac SNA and diaphragmatic electromyography (dEMG), flow probes to record CoBF and cardiac output and a catheter to record arterial pressure. Intracarotid KCN injection was used to activate the CB. To eliminate the contribution of metabolic demand on coronary flow, the heart was paced at a constant rate during CB chemoreflex stimulation. Intra-carotid KCN injection resulted in a significant increase in directly recorded cardiac SNA frequency (from 24±2 to 40±4 bursts/minute; p<0.05) as well as a dose-dependent increase in mean arterial pressure (79±15 to 88±14 mmHg; p<0.01) and CoBF (75±37 Vs 86±42 mL/min; p<0.05). The increase in CoBF and coronary vascular conductance to intracarotid KCN injection was abolished after propranolol infusion, suggesting that the increased cardiac SNA mediates coronary vasodilatation. The pressor response to activation of the CB was abolished by pre-treatment with intravenous atropine but there was no change in the coronary flow response. Our results indicate that CB activation increases directly recorded cardiac SNA which mediates vasodilatation of the coronary vasculature.


2018 ◽  
Vol 24 (25) ◽  
pp. 2906-2910
Author(s):  
Edina Cenko ◽  
Maria Bergami ◽  
Elisa Varotti ◽  
Raffaele Bugiardini

Vasospastic angina is an important cause of chest pain due to coronary artery vasospasm that is related to poor quality of life and can lead to myocardial infarction, arrhythmias and death. Since its first description as “Prinzmetal or variant angina” which was believed to be a focal spam that occurred in non-obstructed epicardial coronary arteries, physician and researchers were gradually confronted with the clinical reality and came to the conclusion that the coronary artery vasospasm was considerably more polymorphic than initially described. Although mechanism leading to vasospastic angina is not completely understood, nowadays the medical community acknowledges that it exhibits a large variability in clinical practice ranging from focal to diffuse epicardial vasospasm. Main proposed mechanisms are impairment of parasympathetic activity, coronary vascular and microvascular dysfunction due to blunted response to nitric oxide endothelium-dependent coronary vasodilatation, increased release of vasoconstricts, and oxidative stress.


2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Irving E. Perez ◽  
Mark A. Menegus ◽  
Cynthia C. Taub

Premenopausal women with chest pain syndrome may have nonatherosclerotic coronary arteries with abnormal coronary flow. Estrogens have cardioprotective effect improving coronary vasodilatation. This case report discusses the consequences of leuprolide use by decreasing estrogen levels which led to acute myocardial infarction.


2014 ◽  
Vol 51 (4) ◽  
pp. 283-289 ◽  
Author(s):  
Ángel Luis García-Villalón ◽  
Miriam Granado ◽  
Luis Monge ◽  
Nuria Fernández ◽  
Gonzalo Carreño-Tarragona ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Khalijah Awang ◽  
Nor Hayati Abdullah ◽  
A. Hamid A. Hadi ◽  
Yew Su Fong

The dichloromethane (DCM) extract ofAndrographis paniculataNees was tested for cardiovascular activity. The extract significantly reduced coronary perfusion pressure by up to24.5±3.0 mm Hg at a 3 mg dose and also reduced heart rate by up to49.5±11.4 beats/minute at this dose. Five labdane diterpenes, 14-deoxy-12-hydroxyandrographolide (1), 14-deoxy-11,12-didehydroandrographolide (2), 14-deoxyandrographolide (3), andrographolide (4), and neoandrographolide (5), were isolated from the aerial parts of this medicinal plant. Bioassay-guided studies using animal model showed that compounds, (2) and (3) were responsible for the coronary vasodilatation. This study also showed that andrographolide (4), the major labdane diterpene in this plant, has minimal effects on the heart.


Sign in / Sign up

Export Citation Format

Share Document